For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Privia Health Group Inc (NASDAQ: PRVA) closed at $18.03 down -4.40% from its previous closing price of $18.86. In other words, the price has decreased by -$4.40 from its previous closing price. On the day, 1.27 million shares were traded. PRVA stock price reached its highest trading level at $18.71 during the session, while it also had its lowest trading level at $17.0.
Ratios:
For a deeper understanding of Privia Health Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.50. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on April 22, 2024, initiated with a Buy rating and assigned the stock a target price of $25.
On March 06, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $22.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 30 ’24 when Mehrotra Parth sold 12,219 shares for $18.42 per share. The transaction valued at 225,074 led to the insider holds 261,640 shares of the business.
Morris Matthew Shawn sold 11,059 shares of PRVA for $203,707 on Apr 30 ’24. The Director now owns 70,101 shares after completing the transaction at $18.42 per share. On Apr 30 ’24, another insider, Mountcastle David, who serves as the EVP & Chief Financial Officer of the company, sold 2,320 shares for $18.42 each. As a result, the insider received 42,734 and left with 259,959 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2239091712 and an Enterprise Value of 1900938112. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 120.04, and their Forward P/E ratio for the next fiscal year is 59.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.27 while its Price-to-Book (P/B) ratio in mrq is 3.80. Its current Enterprise Value per Revenue stands at 1.147 whereas that against EBITDA is 69.934.
Stock Price History:
Over the past 52 weeks, PRVA has reached a high of $30.15, while it has fallen to a 52-week low of $17.54. The 50-Day Moving Average of the stock is -7.71%, while the 200-Day Moving Average is calculated to be -18.54%.
Shares Statistics:
For the past three months, PRVA has traded an average of 909.04K shares per day and 872870 over the past ten days. A total of 118.22M shares are outstanding, with a floating share count of 101.96M. Insiders hold about 14.01% of the company’s shares, while institutions hold 94.52% stake in the company. Shares short for PRVA as of 1713139200 were 6118300 with a Short Ratio of 6.73, compared to 1710460800 on 7297225. Therefore, it implies a Short% of Shares Outstanding of 6118300 and a Short% of Float of 8.32.
Earnings Estimates
As of right now, 14.0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.05 for the current quarter, with a high estimate of $0.07 and a low estimate of $0.03, while EPS last year was $0.06. The consensus estimate for the next quarter is $0.06, with high estimates of $0.08 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.33 and $0.17 for the fiscal current year, implying an average EPS of $0.24. EPS for the following year is $0.33, with 14.0 analysts recommending between $0.4 and $0.23.
Revenue Estimates
A total of 10 analysts believe the company’s revenue will be $680M this quarter.It ranges from a high estimate of $700M to a low estimate of $652.3M. As of the current estimate, Privia Health Group Inc’s year-ago sales were $658.9MFor the next quarter, 10 analysts are estimating revenue of $703.83M. There is a high estimate of $718.1M for the next quarter, whereas the lowest estimate is $690.8M.
A total of 10 analysts have provided revenue estimates for PRVA’s current fiscal year. The highest revenue estimate was $2.89B, while the lowest revenue estimate was $2.81B, resulting in an average revenue estimate of $2.84B. In the same quarter a year ago, actual revenue was $2.84BBased on 10 analysts’ estimates, the company’s revenue will be $3.26B in the next fiscal year. The high estimate is $3.51B and the low estimate is $3.15B.
